MVASI - Cost

Last Updated: April 1st, 2024



HCPCS Code Descriptor:

Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

Medicare Payment Limit:

The MVASI Medicare Payment Limit is $26.75

Average Sale Price:

MVASI ASP cost available once logged in. Mvasi is a biosimilar drug making the ASP calculation more complex. Mvasi's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The MVASI Medicare Co-insurance percentage is 20%. MVASI's Medicare Co-insurance amount is $5.35 per HCPCS unit.

APC Code:

The Mvasi APC Code is: 9329

APC Payment Limit:

The APC Payment Limit for MVASI is available. Login to view.

Mvasi Cost Information:

Mvasi’s active ingredient is bevacizumab and is a biosimilar to the reference product Avastin. Mvasi’s HCPCS code: Q5107 became effective in January of 2019 but its two NDCs did not become effective until August of 2019. Mvasi took a list price increase two years later on August 18th, 2021. Since Mvasi’s average sales price was first published in October of 2019, its ASP has been steadily decreasing due to competition among the biosimilar class.


Mvasi’s wholesale acquisition cost (WAC) information was last updated on:
August 18, 2021
Mvasi’s average wholesale price (AWP) information was last updated on:
August 18, 2021